February 4, 2022

RLS Foundation Funded Opioid Registry Finds COVID-19 Effect

The RLS Foundation is pleased to announce the publication of the article “Restless Legs Syndrome Severity in the National RLS Opioid Registry During the COVID-19 Pandemic” in the online January 2022 edition of Sleep Medicine.

The National Opioid Registry, funded by the RLS Foundation, is a longitudinal study to evaluate the use of an opioid medication in the treatment of refractory RLS.

The first of its kind, the study evaluates the impact of COVID-19 on RLS severity in this population. An increase in RLS symptom severity was found in this group during the early stages of the pandemic. The study highlights the need for clinicians to monitor and manage changes in patients' RLS symptoms during times of uncertainty with global impacts.

Free access to the article with no signup or registration required is available until March 26, 2022 here:

https://authors.elsevier.com/a/1eXMt4y2Nr15Bu